Childhood Mesothelioma
Mesothelioma in children and adolescents
TREATMENT READING
Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.
Not medical advice · Not a complete treatment or trial directory
Made by Triangle.
Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
Source: Childhood Mesothelioma, National Cancer Institute.
Source updated: February 18, 2021. Captured 2026-09-09.
Treatment options for children with mesothelioma
There are different types of treatment for children with mesothelioma.
Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment.
Sources: clinical trials · research study
Because cancer in children is rare, taking part in a clinical trial should be considered. Some clinical trials are open only to patients who have not started treatment.
This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.
Source: Childhood Mesothelioma, National Cancer Institute.
Source updated: February 18, 2021. Captured 2026-09-09.
Treatment will be overseen by a pediatric oncologist, a doctor who specializes in treating children with cancer. The pediatric oncologist works with other pediatric health professionals who are experts in treating children with cancer and who specialize in certain areas of medicine. This may include the following specialists and others:
Sources: pediatric oncologist · pediatric · medicine · specialists
Pediatrician.
Sources: Pediatrician
Pediatric surgeon.
Sources: Pediatric surgeon
Radiation oncologist.
Sources: Radiation oncologist
Pathologist.
Sources: Pathologist
Pediatric nurse specialist.
Sources: Pediatric nurse specialist
Social worker.
Sources: Social worker
Rehabilitation specialist.
Sources: Rehabilitation specialist
Psychologist.
Sources: Psychologist
Child-life specialist.
Sources: Child-life specialist
Three types of treatment are used:
Source: Childhood Mesothelioma, National Cancer Institute.
Source updated: February 18, 2021. Captured 2026-09-09.
Source: Childhood Mesothelioma, National Cancer Institute.
Source updated: February 18, 2021. Captured 2026-09-09.
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy).
Sources: Chemotherapy · drugs · injected · vein · systemic chemotherapy
Source: Childhood Mesothelioma, National Cancer Institute.
Source updated: February 18, 2021. Captured 2026-09-09.
Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. External radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer.
Sources: Radiation therapy · x-rays · radiation · External radiation therapy
Source: Childhood Mesothelioma, National Cancer Institute.
Source updated: February 18, 2021. Captured 2026-09-09.
This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.
Sources: clinical trials
Source: Childhood Mesothelioma, National Cancer Institute.
Source updated: February 18, 2021. Captured 2026-09-09.
Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells. Targeted therapies usually cause less harm to normal cells than chemotherapy or radiation therapy do.
Sources: Targeted therapy
Targeted therapy is being studied for the treatment of childhood mesothelioma that has recurred (come back).
Sources: recurred
Source: Childhood Mesothelioma, National Cancer Institute.
Source updated: February 18, 2021. Captured 2026-09-09.
Immunotherapy is a treatment that uses the patient's immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body's natural defenses against cancer.
Sources: Immunotherapy · immune system
Source: Childhood Mesothelioma, National Cancer Institute.
Source updated: February 18, 2021. Captured 2026-09-09.
Treatment of childhood mesothelioma
Treatment of newly diagnosed mesothelioma in children may include the following:
Sources: diagnosed
Surgery to remove the part of the chest lining with cancer and some of the healthy tissue around it.
Chemotherapy.
Sources: Chemotherapy
Radiation therapy, as palliative therapy, to relieve pain and improve quality of life.
Sources: Radiation therapy · palliative therapy · quality of life
Clinical trials of newer drugs and immunotherapy.
Sources: Clinical trials · drugs · immunotherapy
Source: Childhood Mesothelioma, National Cancer Institute.
Source updated: February 18, 2021. Captured 2026-09-09.
Treatment of recurrent childhood mesothelioma
Treatment of recurrent mesothelioma in children may include the following:
Sources: recurrent
A clinical trial that checks a sample of the patient's tumor for certain gene changes. The type of targeted therapy that will be given to the patient depends on the type of gene change.
Sources: clinical trial · tumor · gene · targeted therapy
Source: Childhood Mesothelioma, National Cancer Institute.
Source updated: February 18, 2021. Captured 2026-09-09.
Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.
Sources: side effects
Clinical trials are taking place in many parts of the country. Find clinical trials for mesothelioma at Treatment Clinical Trials for Mesothelioma. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website. General information about clinical trials is also available.
Sources: Treatment Clinical Trials for Mesothelioma · ClinicalTrials.gov · General information
Source: Childhood Mesothelioma, National Cancer Institute.
Source updated: February 18, 2021. Captured 2026-09-09.
Side effects of treatment for childhood mesothelioma
To learn more about side effects that begin during treatment for cancer, visit Side Effects.
Sources: side effects · Side Effects
Side effects from cancer treatment that begin after treatment and continue for months or years are called late effects. Late effects of cancer treatment may include:
Sources: late effects
Physical problems.
Changes in mood, feelings, thinking, learning, or memory.
Second cancers (new types of cancer) or other conditions.
Sources: Second cancers · conditions
Some late effects may be treated or controlled. It is important to talk with your child's doctors about the possible late effects caused by some treatments.
Source: Childhood Mesothelioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 16, 2024. Captured 2026-09-09.
Cancer in children and adolescents is rare, although the overall incidence has slowly increased since 1975.[1] Children and adolescents with cancer should be referred to medical centers that have a multidisciplinary team of cancer specialists with experience treating the cancers that occur during childhood and adolescence. This multidisciplinary team approach incorporates the skills of the following pediatric specialists and others to ensure that children receive treatment, supportive care, and rehabilitation to achieve optimal survival and quality of life:
Sources: 1
Primary care physicians.
Pediatric surgeons.
Pathologists.
Pediatric radiation oncologists.
Pediatric medical oncologists and hematologists.
Ophthalmologists.
Rehabilitation specialists.
Pediatric oncology nurses.
Social workers.
Child-life professionals.
Psychologists.
Nutritionists.
For specific information about supportive care for children and adolescents with cancer, see the summaries on Supportive and Palliative Care.
Sources: Supportive and Palliative Care
The American Academy of Pediatrics has outlined guidelines for pediatric cancer centers and their role in the treatment of children and adolescents with cancer.[2] At these centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate is offered to most patients and their families. Clinical trials for children and adolescents diagnosed with cancer are generally designed to compare potentially better therapy with current standard therapy. Other types of clinical trials test novel therapies when there is no standard therapy for a cancer diagnosis. Most of the progress in identifying curative therapies for childhood cancers has been achieved through clinical trials. Information about ongoing clinical trials is available from the NCI website.
Sources: 2 · NCI website
Dramatic improvements in survival have been achieved for children and adolescents with cancer. Between 1975 and 2020, childhood cancer mortality decreased by more than 50%.[3-5] Childhood and adolescent cancer survivors require close monitoring because side effects of cancer therapy may persist or develop months or years after treatment. For information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors, see Late Effects of Treatment for Childhood Cancer.
Sources: 3 · 5 · Late Effects of Treatment for Childhood Cancer
Childhood cancer is a rare disease, with about 15,000 cases diagnosed annually in the United States in individuals younger than 20 years.[6] The U.S. Rare Diseases Act of 2002 defines a rare disease as one that affects populations smaller than 200,000 people in the United States. Therefore, all pediatric cancers are considered rare.
Sources: 6 · Rare Diseases Act of 2002
The designation of a rare tumor is not uniform among pediatric and adult groups. In adults, rare cancers are defined as those with an annual incidence of fewer than six cases per 100,000 people. They account for up to 24% of all cancers diagnosed in the European Union and about 20% of all cancers diagnosed in the United States.[7,8] In children and adolescents, the designation of a rare tumor is not uniform among international groups, as follows:
A consensus effort between the European Union Joint Action on Rare Cancers and the European Cooperative Study Group for Rare Pediatric Cancers estimated that 11% of all cancers in patients younger than 20 years could be categorized as very rare. This consensus group defined very rare cancers as those with annual incidences of fewer than two cases per 1 million people. However, three additional histologies (thyroid carcinoma, melanoma, and testicular cancer) with incidences of more than two cases per 1 million people were also included in the very rare group due to a lack of knowledge and expertise in the management of these tumors.[9]
Sources: 9
The Children's Oncology Group defines rare pediatric cancers as those listed in the International Classification of Childhood Cancer subgroup XI, which includes thyroid cancers, melanomas and nonmelanoma skin cancers, and multiple types of carcinomas (e.g., adrenocortical carcinomas, nasopharyngeal carcinomas, and most adult-type carcinomas such as breast cancers and colorectal cancers).[10] These diagnoses account for about 5% of the cancers diagnosed in children aged 0 to 14 years and about 27% of the cancers diagnosed in adolescents aged 15 to 19 years.[4] Most cancers in subgroup XI are either melanomas or thyroid cancers, with other cancer types accounting for only 2% of the cancers diagnosed in children aged 0 to 14 years and 9.3% of the cancers diagnosed in adolescents aged 15 to 19 years.
These rare cancers are extremely challenging to study because of the relatively few patients with any individual diagnosis, the predominance of rare cancers in the adolescent population, and the small number of clinical trials for adolescents with rare cancers.
Information about these tumors may also be found in sources relevant to adults with cancer, such as Malignant Mesothelioma Treatment.
Sources: Malignant Mesothelioma Treatment
Source: Childhood Mesothelioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 16, 2024. Captured 2026-09-09.
Treatment options for pediatric patients with malignant pleural mesotheliomas are controversial. Outcomes are often poor in these individuals despite treatment with radical surgical resection, chemotherapy, and radiation therapy. Treatments that use newer chemotherapy agents and immunotherapies are under investigation.[1]
Sources: 1
Treatment options for childhood malignant mesothelioma include the following:
Surgery.
Sources: Surgery
Chemotherapy.
Sources: Chemotherapy
Surgery and hyperthermic compartmental chemotherapy.
Sources: Surgery and hyperthermic compartmental chemotherapy
Radiation therapy.
Sources: Radiation therapy
Targeted therapy (ceritinib).
Sources: Targeted therapy (ceritinib)
Source: Childhood Mesothelioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 16, 2024. Captured 2026-09-09.
Radical surgical resection has been attempted in patients with mesotheliomas, with mixed results.[2] In adults, durable responses may be achieved with multimodal therapy that includes extrapleural pneumonectomy and radiation therapy after combination chemotherapy with pemetrexed-cisplatin.[3][Level of evidence B4] However, this approach remains highly controversial.[4]
Sources: 2 · 3 · Level of evidence B4 · 4
Source: Childhood Mesothelioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 16, 2024. Captured 2026-09-09.
The European Cooperative Study Group on Pediatric Rare Tumors retrospectively reviewed children, adolescents, and young adults (aged ≤21 years) with mesotheliomas who were treated between 1987 and 2018.[5] Investigators identified 15 male patients and 18 female patients with mesotheliomas. Only one patient had a documented asbestos exposure. In most patients, the primary tumor was located in the peritoneum (23 patients). Tumor histologies were either multicystic mesothelioma of the peritoneum (6 patients) or malignant mesothelioma (27 patients).
Sources: 5
The response rate to treatment with cisplatin-pemetrexed was 50% (6 of 12 cases).
After a median follow-up period of 6.7 years (range, 0–20 years), the 5-year overall survival rate was 82.3%, and the event-free survival rate was 45.1%.
All patients with multicystic mesothelioma remained alive after either surgery (5 patients) or cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (1 patient).
Source: Childhood Mesothelioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 16, 2024. Captured 2026-09-09.
Hyperthermic intrapleural/intraperitoneal chemotherapy (HIPEC) has been used to treat pleural and intraperitoneal mesotheliomas. HIPEC, in conjunction with radical surgical resection, has been used to treat adults with pleural mesotheliomas. Although results have been encouraging, HIPEC has not been validated in controlled clinical trials because pleural mesotheliomas are rare.[1,6,7] A single-institution study followed seven children with intraperitoneal mesotheliomas who were treated with surgery and HIPEC.[8] At last available follow-up, five of the seven patients were alive and had either minimal disease or no evaluable disease.
Source: Childhood Mesothelioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 16, 2024. Captured 2026-09-09.
Pain is an infrequent symptom in patients with mesotheliomas. However, if pain occurs, radiation therapy may be used for palliation.
Source: Childhood Mesothelioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 16, 2024. Captured 2026-09-09.
In one case report, a 13-year-old patient with a peritoneal mesothelioma and a STRN::ALK fusion gene responded to ceritinib treatment.[9]
Sources: 9
For more information, see Malignant Mesothelioma Treatment.
Sources: Malignant Mesothelioma Treatment
Source: Childhood Mesothelioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 16, 2024. Captured 2026-09-09.
Information about National Cancer Institute (NCI)–supported clinical trials can be found on the NCI website. For information about clinical trials sponsored by other organizations, see the ClinicalTrials.gov website.
Sources: NCI website · ClinicalTrials.gov website
Mesothelioma in children and adolescents
Treatment of recurrent childhood mesothelioma